Theodor Voiosu

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

Marc Ferrante, Geert D’Haens, Vipul Jairath et al. · The Lancet · 2024 · 76 citations

Moderately-to-severely Active Crohn, Immunology, Gastroenterology +5

Wet-suction versus slow-pull technique for endoscopic ultrasound-guided fine-needle biopsy: a multicenter, randomized, crossover trial

Stefano Francesco Crinò, Maria Cristina Conti Bellocchi, Roberto Di Mitri et al. · Endoscopy · 2022 · 69 citations · Full text

Prevalence and impact on survival of hepatopulmonary syndrome and cirrhotic cardiomyopathy in a cohort of cirrhotic patients

Andrei Voiosu, I. Daha, Theodor Voiosu et al. · Liver International · 2015 · 45 citations

Impact of trainee involvement on the outcome of ERCP procedures: results of a prospective multicenter observational trial

Theodor Voiosu, Ivo Boškoski, Andrei Voiosu et al. · Endoscopy · 2019 · 43 citations

Th17 and IL-17 immunity in chronic hepatitis C infection.

Paul Bălănescu, Anca Lădaru, Theodor Voiosu et al. · PubMed · 2012 · 33 citations

T-regulatory Cell, Immunology, Pathology +21